Private Advisory Group LLC Sells 32,274 Shares of VanEck Pharmaceutical ETF (NASDAQ:PPH)

Private Advisory Group LLC lowered its position in VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report) by 84.9% during the 3rd quarter, according to the company in its most recent Form 13F filing with the SEC. The firm owned 5,720 shares of the company’s stock after selling 32,274 shares during the quarter. Private Advisory Group LLC owned about 0.07% of VanEck Pharmaceutical ETF worth $544,000 at the end of the most recent quarter.

A number of other institutional investors and hedge funds also recently made changes to their positions in the business. Optimum Investment Advisors bought a new position in VanEck Pharmaceutical ETF in the 2nd quarter worth about $27,000. GPS Wealth Strategies Group LLC purchased a new stake in VanEck Pharmaceutical ETF in the second quarter valued at approximately $42,000. CWM LLC purchased a new stake in VanEck Pharmaceutical ETF in the second quarter valued at approximately $55,000. International Assets Investment Management LLC bought a new stake in VanEck Pharmaceutical ETF during the second quarter valued at approximately $86,000. Finally, Comerica Bank grew its stake in VanEck Pharmaceutical ETF by 39.4% in the 1st quarter. Comerica Bank now owns 1,337 shares of the company’s stock worth $121,000 after buying an additional 378 shares in the last quarter.

VanEck Pharmaceutical ETF Price Performance

Shares of NASDAQ:PPH opened at $94.21 on Friday. The company’s fifty day moving average price is $96.02 and its 200-day moving average price is $92.22. The firm has a market capitalization of $719.76 million, a price-to-earnings ratio of 21.04 and a beta of 0.72. VanEck Pharmaceutical ETF has a one year low of $74.05 and a one year high of $99.51.

VanEck Pharmaceutical ETF Company Profile

(Free Report)

The VanEck Pharmaceutical ETF (PPH) is an exchange-traded fund that is based on the MVIS US Listed Pharmaceutical 25 index, a market-cap-weighted index of 25 of the largest global pharmaceutical firms. PPH was launched on Feb 1, 2000 and is managed by VanEck.

Further Reading

• Five stocks we like better than VanEck Pharmaceutical ETF
• Energy and Oil Stocks Explained
• 3 Micro-Caps Set for Major Moves: Balancing Risk and Opportunity
• What is a Dividend King? 
• Autodesk Named a “Top Pick” by Morgan Stanley—Is It Time to Buy?
• How to Most Effectively Use the MarketBeat Earnings Screener
• 4 Quirky ETFs With Big Potential for Impressive Gains

Want to see what other hedge funds are holding PPH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for VanEck Pharmaceutical ETF (NASDAQ:PPH – Free Report).